Christina Furebring (Former)
1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
(
- Contribution to journal › Article
- 2017
-
Mark
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
(
- Contribution to journal › Article
- 2009
-
Mark
Purification of truncated and mutated chemotaxis inhibitory protein of Staphylococcus aureus—an anti-inflammatory protein
(
- Contribution to journal › Article
- 2004
-
Mark
Profiling of internalizing tumor-associated antigens on breast and pancreatic cancer cells by reversed genomics
(
- Contribution to journal › Article
-
Mark
A novel mammalian display system for the selection of protein-protein interactions by decoy receptor engagement
(
- Contribution to journal › Article
- 2003
-
Mark
Affinity and Epitope Profiling of Mouse Anti-CD40 Monoclonal Antibodies
(
- Contribution to journal › Article
-
Mark
Pre-assembly of the extracellular domains of CD40 is not necessary for rescue of naïve B-cells from anti-IgM induced apoptosis
2003) p.01-14(
- Contribution to conference › Paper, not in proceeding
-
Mark
Pre-assembly of the extracellular domains of CD40 is not necessary for rescue of mouse B cells from anti-immunoglobulin M-induced apoptosis
(
- Contribution to journal › Article
-
Mark
Internalising human anti-tumor antibodies.
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2002
-
Mark
In vitro molecular evolution of antibody genes mimicking receptor revision
(
- Contribution to journal › Article